Dr Tamara Denise Spriggs, MD, MPH | |
140 W 11th St, Front Royal, VA 22630-3512 | |
(540) 631-3700 | |
(540) 635-1673 |
Full Name | Dr Tamara Denise Spriggs |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 17 Years |
Location | 140 W 11th St, Front Royal, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265637953 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0101245822 (Virginia) | Primary |
207Q00000X | Family Medicine | 24251 (West Virginia) | Secondary |
207Q00000X | Family Medicine | D0072391 (Maryland) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Winchester Medical Center Hha | Winchester, VA | Home health agency |
Warren Memorial Hospital | Front royal, VA | Hospital |
Shenandoah Memorial Hospital | Woodstock, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Warren Memorial Hospital, Inc. | 2365330347 | 71 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.
Traumatic events early in life can increase levels of norepinephrine—the primary hormone responsible for preparing the body to react to stressful situations—in the gut, increasing the risk of developing chronic indigestion and anxiety during adulthood, a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology reports.
When slim men suffer bouts of low blood sugar, chances are that they will make unfair decisions involving the more rotund people they engage with in the workplace.
› Verified 1 days ago
Entity Name | Shenandoah Memorial Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952417735 PECOS PAC ID: 2466360375 Enrollment ID: O20040115001156 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.
Traumatic events early in life can increase levels of norepinephrine—the primary hormone responsible for preparing the body to react to stressful situations—in the gut, increasing the risk of developing chronic indigestion and anxiety during adulthood, a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology reports.
When slim men suffer bouts of low blood sugar, chances are that they will make unfair decisions involving the more rotund people they engage with in the workplace.
› Verified 1 days ago
Entity Name | Warren Memorial Hospital, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164442281 PECOS PAC ID: 2365330347 Enrollment ID: O20040310000516 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.
Traumatic events early in life can increase levels of norepinephrine—the primary hormone responsible for preparing the body to react to stressful situations—in the gut, increasing the risk of developing chronic indigestion and anxiety during adulthood, a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology reports.
When slim men suffer bouts of low blood sugar, chances are that they will make unfair decisions involving the more rotund people they engage with in the workplace.
› Verified 1 days ago
Entity Name | Front Royal Family Practice, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750434072 PECOS PAC ID: 2769409705 Enrollment ID: O20051028000336 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.
Traumatic events early in life can increase levels of norepinephrine—the primary hormone responsible for preparing the body to react to stressful situations—in the gut, increasing the risk of developing chronic indigestion and anxiety during adulthood, a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology reports.
When slim men suffer bouts of low blood sugar, chances are that they will make unfair decisions involving the more rotund people they engage with in the workplace.
› Verified 1 days ago
Entity Name | Valley Physician Enterprise Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538316203 PECOS PAC ID: 9931268091 Enrollment ID: O20081104000278 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.
Traumatic events early in life can increase levels of norepinephrine—the primary hormone responsible for preparing the body to react to stressful situations—in the gut, increasing the risk of developing chronic indigestion and anxiety during adulthood, a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology reports.
When slim men suffer bouts of low blood sugar, chances are that they will make unfair decisions involving the more rotund people they engage with in the workplace.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Tamara Denise Spriggs, MD, MPH 140 W 11th St, Front Royal, VA 22630-3512 Ph: (540) 631-3700 | Dr Tamara Denise Spriggs, MD, MPH 140 W 11th St, Front Royal, VA 22630-3512 Ph: (540) 631-3700 |
News Archive
RetroVirox, Inc., a biotechnology company specializing in the development of novel antivirals, announced today that it has received a grant award of $296,875 from the National Institute of Allergy and Infectious Disease (NIAID), of the National Institutes of Health (NIH). This is the second award to RetroVirox from the NIH in less than six months. In March 2009 the company received its first grant to develop novel inhibitors of HIV entry.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Undoubtedly, the best available treatment for all liver tumors is complete surgical resection. However, the synthetic somatostatin analogue octreotide has been found effective in inhibiting tumor growth in a variety of experimental models. It has been reported that octreotide inhibits the proliferation and induces apoptosis of different HCC cell lines in vitro.
Traumatic events early in life can increase levels of norepinephrine—the primary hormone responsible for preparing the body to react to stressful situations—in the gut, increasing the risk of developing chronic indigestion and anxiety during adulthood, a new study in American Journal of Physiology—Gastrointestinal and Liver Physiology reports.
When slim men suffer bouts of low blood sugar, chances are that they will make unfair decisions involving the more rotund people they engage with in the workplace.
› Verified 1 days ago
Dr. Craig Hudgins Phillips, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 67 Riverton Commons Dr, Front Royal, VA 22630 Phone: 540-635-0848 | |
Jeffery Groesbeck, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 351 Valley Health Way # 300, Front Royal, VA 22630 Phone: 540-631-3700 | |
Trieu Thi-hai Vo, Family Medicine Medicare: Medicare Enrolled Practice Location: 351 Valley Health Way Ste 300, Front Royal, VA 22630 Phone: 540-631-3700 | |
Claudine Nigro, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 W 11th St, Front Royal, VA 22630 Phone: 949-274-5593 | |
Samuel Woo Lee, Family Medicine Medicare: Medicare Enrolled Practice Location: 351 Valley Health Way Ste 300, Front Royal, VA 22630 Phone: 540-631-3700 Fax: 540-635-1673 | |
Candace Jill Wise, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 351 Valley Health Way # 300, Front Royal, VA 22630 Phone: 540-631-3700 |